Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans

Bone

Volumn 59, Issue , 2014, Pages 1-6

  Roforth, Matthew M ^a   Fujita, Koji ^a   McGregor, Ulrike I ^a   Kirmani, Salman ^a   McCready, Louise K ^a   Peterson, James M ^a   Drake, Matthew T ^a   Monroe, David G ^a   Khosla, Sundeep ^a  

^a MAYO CLINIC   (United States)

Author keywords

Aging; Bone biopsy; Postmenopausal

Indexed keywords

25 HYDROXYVITAMIN D; BONE MORPHOGENETIC PROTEIN; CARBOXY TERMINAL TELOPEPTIDE; CELL NUCLEUS RECEPTOR; GROWTH FACTOR; JAGGED1; JAGGED2; MEMBRANE PROTEIN; MESSENGER RNA; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; PARATHYROID HORMONE; PROCOLLAGEN C PROTEINASE; SCLEROSTIN; SECRETED FRIZZLED RELATED PROTEIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR HEY 1; TRANSCRIPTION FACTOR HEY 2; TRANSCRIPTION FACTOR HEYL; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

ADULT; AGE; AGED; ARTICLE; BLOOD LEVEL; BONE AGE; BONE BIOPSY; BONE DENSITY; BONE METABOLISM; FEMALE; FRACTURE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MULTIGENE FAMILY; NEEDLE BIOPSY; NORMAL HUMAN; OSSIFICATION; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; UPREGULATION;

AGING; BONE BIOPSY; POSTMENOPAUSAL;

ADIPOGENESIS; ADULT; AGED; AGED, 80 AND OVER; AGING; ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GENETIC MARKERS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MICE; MIDDLE AGED; OSTEOCYTES; PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STEM CELLS; YOUNG ADULT;

EID: 84887542251     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.10.019     Document Type: Article

References (35)

1. Lips P., Courpron P., Meunier P.J. Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age. Calcif Tissue Res 1978, 26:13-17.
2. Khosla S. Pathogenesis of age-related bone loss in humans. J Gerontol A Biol Sci Med Sci 2013, 68:1226-1235.
3. Ke H.Z., Richards W.G., Li X., Ominsky M.S. Sclerostin and dickkopf-1 as therapeutic targets in bone diseases. Endocr Rev 2012, 33:747-783.
4. Modder U.I., Hoey K.A., Amin S., McCready L.K., Achenbach S.J., Riggs B.L., et al. Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res 2011, 26:373-379.
5. Amrein K., Amrein S., Drexler C., Dimai H.P., Dobnig H., Pfeifer K., et al. Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults. J Clin Endocrinol Metab 2012, 97:148-154.
6. Ardawi M.-S.M., Al-Kadi H.A., Rouzi A.A., Qari M.H. Determinants of serum sclerostin in healthy pre- and postmenopausal women. J Bone Miner Res 2011, 26:2812-2822.
7. Lintern K.B., Guidato S., Rowe A., Saldanha J.W., Itasaki N. Characterization of wise protein and its molecular mechanism to interact with Wnt and BMP signals. J Biol Chem 2009, 284:23159-23168.
8. He J.W., Yue H., Hu H.H., Hu Y.Q., Zhang Z.L. Contribution of the sclerostin domain-containing protein 1 (SOSTDC1) gene to normal variation of peak bone mineral density in Chinese women and men. J Bone Miner Res 2011, 29:571-581.
9. Roforth M., Fujita K., Demaray S., McGregor U.I., Kirmani S., McCready L.K., et al. Estrogen reduces sost mRNA and circulating sclerostin levels in postmenopausal women 2013, ASBMR, [Abstract].
10. Estrada K., Styrkarsdottir U., Evangelou E., et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 2012, 44:491-501.
11. Modder U.I., Roforth M.M., Nicks K.M., Peterson J.M., McCready L.K., Monroe D.G., et al. Characterization of mesenchymal progenitor cells isolated from human bone marrow by negative selection. Bone 2012, 50:807-810.
12. Radonic A., Thulke S., Mackay I.M., Landt O., Siegert W., Nitsche A. Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 2004, 313:856-862.
13. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3. [research0034.1-0-34.11].
14. Zhao S., Fernald R.D. Comprehensive algorithm for quantitative real-time polymerase chain reaction. J Comput Biol 2005, 12:1047-1064.
15. Levey A.S., Coresh J., Greene T., Stevens L.A., Zhang Y.L., Hendriksen S., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 145:247-254.
16. O'Brien P.C. Procedures for comparing samples with multiple endpoints. Biometrics 1984, 40:1079-1087.
17. Syed F.A., Modder U.I., Roforth M., Hensen I., Fraser D.G., Peterson J.M., et al. Effects of chronic estrogen treatment on modulating age-related bone loss in female mice. J Bone Miner Res 2010, 25:2438-2446.
18. Modder U.I., Roforth M.M., Hoey K., McCready L.K., Peterson J.M., Monroe D.G., et al. Effects of estrogen on osteoprogenitor cells and cytokines/bone regulatory factors in postmenopausal women. Bone 2011, 49:202-207.
19. Peris P., Atkinson E.J., Gossl M., Kane T.L., McCready L.K., Lerman A., et al. Effects of bisphosphonate treatment on circulating osteogenic endothelial progenitor cells in postmenopausal women. Mayo Clin Proc 2013, 88:46-55.
20. Reiner A., Yekutieli D., Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 2003, 19:368-375.
21. Hirakawa A., Sato Y., Sozu T., Hamada C., Yoshimura I. Estimating the false discovery rate using mixed normal distribution for identifying differentially expressed genes in microarray data analysis. Cancer Inform 2008, 22:140-148.
22. Boudin E., Fijalkowski I., Piters E., Van Hul W. The role of extracellular modulators of canonical Wnt signaling in bone metabolism and diseases. Semin Arthritis Rheum 2013, 43:220-240.
23. Kusu N., Laurikkala J., Imanishi M., Usui H., Konishi M., Miyake A., et al. Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity. J Biol Chem 2003, 278:24113-24117.
24. Pederson L., Ruan M., Westendorf J.J., Khosla S., Oursler M.J. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci USA 2009, 105:20764-20769.
25. Ota K., Quint P., Ruan M., Pederson L., Westendorf J.J., Khosla S., et al. Sclerostin is expressed in osteoclasts from aged mice and reduces osteoclast-mediated stimulation of mineralization. J Cell Biochem 2013, 114:1901-1907.
26. Zhu D., Mackenzie N.C., Millan J.L., Farquharson C., MacRae V.E. The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PLoS One 2011, 6:e19595.
27. Hilton M.J., Tu X., Wu X., Bai S., Zhao H., Kobayashi T., et al. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat Med 2008, 14:306-314.
28. Canalis E., Parker K., Feng J.Q., Zanotti S. Osteoblast lineage-specific effects of notch activation in the skeleton. Endocrinology 2013, 154:623-634.
29. Canalis E., Adams D.J., Boskey A., Parker K., Kranz L., Zanotti S. Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling. J Biol Chem 2013, 288:25614-25625.
30. Fazeli P.K., Horowitz M.C., MacDougald O.A., Scheller E.L., Rodeheffer M.S., Rosen C.J., et al. Marrow fat and bone-new perspectives. J Clin Endocrinol Metab 2013, 98:935-945.
31. Hausler K.D., Horwood N.J., Chuman Y., Fisher J.L., Ellis J., Martin T.J., et al. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation. J Bone Miner Res 2004, 19:1873-1881.
32. Taipaleenmaki H., Abdallah B.M., Aldahmash A., Saamanen A.M., Kassem M. Wnt signaling mediates the cross-talk between bone marrow derived pre-adipocytic and pre-osteoblastic cell populations. Exp Cell Res 2011, 317:745-756.
33. Bodine P.V.N., Zhao W., Kharode Y.P., Bex F.J., Lambert A.J., Goad M.B., et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol 2004, 18:1222-1237.
34. Yao W., Cheng Z., Shahnazari M., Dai W., Johnson M.L., Lane N.E. Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects. J Bone Miner Res 2010, 25:190-199.
35. Fujita K., Roforth M., Peterson J.M., Kirmani S., Drake M., McCready L.K., et al. Isolation and characterization of human osteoblasts from needle biopsies without in vitro culture. Osteoporos Int 2013, [in press], [Epub ahead of print, Oct 11, 2013]. 10.1007/s00198-013-2529-9.